Date published: 
4 January 2021
Intended audience: 
General public
$10 million to support COVID-19 related clinical trials cover

This immediate funding under the MRFF’s Clinical Trials Activity initiative will support six promising Australian innovations, including two ‘next generation’ vaccines and customised 3D-printed face guards.

Read the media release for details about all six clinical trials.